Evaluation of Potassium Iodide (KI) and Ammonium Perchlorate (NH₄ClO₄) to Ameliorate ¹³¹I^- Exposure in the Rat

REFERENCES

• Adams, C. A., and Bonnell, J. A., 1962. Administration of stable iodide as a means of reducing thyroid irradiation resulting from inhalation of radioactive iodine, Hisp. Med. 7 (1962), pp. 127–149.
   Google Scholar
• Amitai, Y., Winston, G., Sack, J., Wasser, J., Lewis, M., Blount, B. C., Valentin-Blasini, L., Fisher, N., Israeli, A., and Leventhal, A., 2007. Gestational exposure to high perchlorate concentrations in drinking water and neonatal thyroxine levels, Thyroid 17 (2007), pp. 843–850.
   PubMed Web of Science ®Google Scholar
• Balonov, M., 2007. Third annual Warren K. Sinclair keynote address: Retrospective analysis of impacts of the Chernobyl accident, Health Phys. 93 (2007), pp. 383–409.
   PubMed Web of Science ®Google Scholar
• Bartalena, L., Brogioni, S., Grasso, L., Bogazzi, F., Burelli, A., and Martino, E., 1996. Treatment of amiodarone-induced thyrotoxicosis, a difficult challenge: Results of a prospective study, J. Clin. Endocrinol. Metab. 81 (1996), pp. 2930–2933.
   PubMed Web of Science ®Google Scholar
• Blum, M., and Eisenbud, M., 1967. Reduction of thyroid irradiation from 131-I by potassium iodide, J. Am. Med. Assoc. 200 (1967), pp. 1036–1040.
   PubMed Web of Science ®Google Scholar
• Crocker, D. G., 1984. Nuclear reactor accidents—The use of KI as a blocking agent against radioiodine uptake in the thyroid—A review, Health Phys. 46 (1984), pp. 1265–1279.
   PubMed Web of Science ®Google Scholar
• Food and Drug Administration, , 2001. Food and Drug Administration, , ed. Guidance, Potassium iodide as a thyroid blocking agent in radiation emergencies. Vol. 66. Washington, DC: U.S. Department of Health and Human Services and Center for Drug Evaluation and Research; 2001. pp. 1–15.
   Google Scholar
• Godley, A. F., and Stanbury, J. B., 1954. Preliminary experience in the treatment of hyperthyroidism with potassium perchlorate, J Clin Endocrinol Metab 14 (1954), pp. 70–78.
   PubMed Web of Science ®Google Scholar
• Goldman, S. J., and Stanbury, J. B., 1973. The metabolism of perchlorate in the rat, Endocrinology 92 (1973), pp. 1536–1538.
   PubMed Web of Science ®Google Scholar
• Kroizman-Sheiner, E., Brickner, D., Canfi, A., and Schwarzfuchs, D., 2005. [Blocking of the thyroid against I-131 following a nuclear disaster], Harefuah 144 (2005), pp. 497–501.
   PubMedGoogle Scholar
• Lengemann, F. W., and Swanson, E. W., 1957. A study of the secretion of iodine in milk of dairy cows, using daily oral doses of I131, J. Dairy Sci. 40 (1957), pp. 216–224.
   Web of Science ®Google Scholar
• Lengemann, F. W., and Thompson, J. C., 1963. Prophylactic and therapeutic measures for radioiodine contamination—A review, Health Phys. 9 (1963), pp. 1391–1397.
   PubMedGoogle Scholar
• Levin, R. J., 2008. Incidence of thyroid cancer in residents surrounding the Three Mile Island nuclear facility, Laryngoscope 118 (2008), pp. 618–628.
   PubMed Web of Science ®Google Scholar
• Lomat, L., Galburt, G., Quastel, M. R., Polyakov, S., Okeanov, A., and Rozin, S., 1997. Incidence of childhood disease in Belarus associated with the Chernobyl accident, Environ. Health Perspect 105 (Suppl. 6) (1997), pp. 1529–1532.
   PubMed Web of Science ®Google Scholar
• Morimoto, I., Yoshimoto, Y., Sato, K., Hamilton, H. B., Kawamoto, S., Izumi, M., and Nagataki, S., 1987. Serum TSH, thyroglobulin, and thyroidal disorders in atomic bomb survivors exposed in youth: 30-Year follow-up study, J. Nucl. Med. 28 (1987), pp. 1115–1122.
   PubMed Web of Science ®Google Scholar
• Nauman, J., and Wolff, J., 1993. Iodide prophylaxis in Poland after the Chernobyl reactor accident: Benefits and risks, Am. J. Med. 94 (1993), pp. 524–532.
   PubMed Web of Science ®Google Scholar
• Pahuja, D. N., Rajan, M. G., Borkar, A. V., and Samuel, A. M., 1993. Potassium iodate and its comparison to potassium iodide as a blocker of 131I uptake by the thyroid in rats, Health Phys. 65 (1993), pp. 545–549.
   PubMed Web of Science ®Google Scholar
• Pennington, J. A., 1990. A review of iodine toxicity reports, J. Am. Diet Assoc. 90 (1990), pp. 1571–1581.
   PubMed Web of Science ®Google Scholar
• Plummer, H. S., 1923. Results of administering iodine to patients having exophthalmic goiter, J. Am. Med. Assoc. 80 (1923), p. 1955.
   Google Scholar
• Pochin, E. E., and Barnaby, C. F., 1962. The effect of pharmacological doses of non-radioactive iodide on the course of radio-iodine uptake by the thyroid, Health Phys. 7 (1962), pp. 125–126.
   PubMedGoogle Scholar
• Ramsden, D., Passant, F. H., Peabody, C. O., and Speight, R. G., 1967. Radioiodine uptakes in the thyroid. Studies of the blocking and subsequent recovery of the gland following the administration of stable iodine, Health Phys. 13 (1967), pp. 633–646.
   PubMed Web of Science ®Google Scholar
• Robbins, J., and Schneider, A. B., 1998. Radioiodine-induced thyroid cancer: Studies in the aftermath of the accident at Chernobyl, Trends Endocrinol. Metab. 9 (1998), pp. 87–94.
   PubMed Web of Science ®Google Scholar
• Saxena, K. M., Chapman, E. M., and Pryles, C. V., 1962. Minimal dosage of iodide required to suppress uptake of iodine-131 by normal thyroid, Science 138 (1962), pp. 430–431.
   PubMed Web of Science ®Google Scholar
• Stanbury, J. B., and Wyngaarden, J. B., 1952. Effect of perchlorate on the human thyroid gland, Metabolism 1 (1952), pp. 533–539.
   PubMed Web of Science ®Google Scholar
• Trotter, W. R., 1962. The relative toxicity of antithyroid drugs, J. New Drugs 2 (1962), pp. 333–343.
   PubMedGoogle Scholar
• Valentin-Blasini, L., Blount, B. C., and Delinsky, A., 2007. Quantification of iodide and sodium-iodide symporter inhibitors in human urine using ion chromatography tandem mass spectrometry, J. Chromatogr. A 1155 (2007), pp. 40–46.
   PubMed Web of Science ®Google Scholar
• Verger, P., Aurengo, A., Geoffroy, B., and Le Guen, B., 2001. Iodine kinetics and effectiveness of stable iodine prophylaxis after intake of radioactive iodine: A review, Thyroid 11 (2001), pp. 353–360.
   PubMed Web of Science ®Google Scholar
• Wolff, J., 1980. Physiological Aspects of iodide excess in relation to radiation protection, J. Mol. Med. 4 (1980), pp. 151–165.
   Google Scholar
• Wolff, J., 1998. Perchlorate and the thyroid gland, Pharmacol. Rev. 50 (1998), pp. 89–105.
   PubMed Web of Science ®Google Scholar
• Wolff, J., and Chaikoff, I. L., 1948. Plasma inorganic iodide as a homeostatic regulator of thyroid function, J Biol Chem 174 (1948), pp. 555–564.
   PubMed Web of Science ®Google Scholar
• Yu, K. O., Narayanan, L., Mattie, D. R., Godfrey, R. J., Todd, P. N., Sterner, T. R., Mahle, D. A., Lumpkin, M. H., and Fisher, J. W., 2002. The pharmacokinetics of perchlorate and its effect on the hypothalamus-pituitary-thyroid axis in the male rat, Toxicol Appl Pharmacol 182 (2002), pp. 148–159.
   PubMed Web of Science ®Google Scholar
• Zanzonico, P. B., and Becker, D. V., 2000. Effects of time of administration and dietary iodine levels on potassium iodide (KI) blockade of thyroid irradiation by 131I from radioactive fallout, Health Phys 78 (2000), pp. 660–667.
   PubMed Web of Science ®Google Scholar